Pfizer Inc.

The share price appreciation is giving Wall Street confidence that after a prolonged "winter" in biotech is finally beginning to thaw

Biotech stocks have revived after five years of stagnation. Why is growth far from complete?

NIKE, Inc.

Spotify Technology S.A.

CoreWeave, Inc.

UiPath Inc.

Alcoa Corporation

Paychex, Inc.

Daily review and forecast of events on the U.S. stock market from Mikhail Denislamov, Deputy Director of Freedom Capital Markets Research.

Morning in New York: focus on the aftermath of the U.S. government shutdown

Merck & Co., Inc.

Pfizer received a three-year reprieve from 100 percent duties on drug imports in exchange for lower prices

Pfizer struck a price deal with the White House. Shares soared 6%

Metsera, Inc.

Pharmaceutical giant Pfizer, best known for its COVID-19 vaccine Pfizer has <a href="https://www.businesswire.com/news/home/20250922965053/en/Pfizer-to-Acquire-Metsera-and-its-Next-Generation-Obesity-Portfolio?utm_source=chatgpt.com">revealed </a>it is buying weight-loss drug developer Metsera for $4.9 billion, a move that will allow Pfizer to step up its bet on solutions in the popular obesity treatment area, AP <a href="https://apnews.com/article/pfizer-metsera-obesity-treatments-e85141f89b670b8d9a7520de3a2fd7c5">notes</a>.

Pfizer will buy a company that develops obesity remedies. Its shares soared 60%

Palantir Technologies Inc.

Tesla, Inc.

Morning in New York: chances for continued growth persist


Eli Lilly and Company

Novo Nordisk A/S

The US President sent letters to 17 pharmaceutical market leaders

#: 6